Patent details

Herbas

VPB

Print

EN | LT

Supplementary protection

LT - Antivirusinis 1-fenil-2,5-dibenzimidazol-5-il-pirolidino darinys

EN - An antiviral 1-phenyl-2,5-dibenzimidazol-5-yl-pyrrolidine derivative

SPC
(11)	Number of the document	C 2692346
(68)	Number of the document	2692346
(21)	Application number for Supplementary Protection Certificate	PA 2017 033
(22)	Date of filing the application	2017-10-24
(41)	Date of publication of the application	2017-11-10
	Date of publication of SPC	2018-06-25
(24)	Date of coming into effect of SPC	2031-10-13

Applicant
(71)	AbbVie Bahamas Ltd., Sassoon House Shirley Street & Victoria Avenue, New Providence, Nassau, BS

Grantee
(73)	AbbVie Manufacturing Management Unlimited Company , 70 Sir John Rogerson's Quay, Dublin 2, IE

Attorney or representative
(74)	Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT

Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93)	EU/1/17/1213, 2017-07-26

Calculated date of expiry of the SPC
(94)	2032-07-28

Name of the product protected by the basic patent
(95)	Pibrentasviras arba jo farmaciniu požiūriu priimtina druska

Paediatric extension
	Request filed	SPC extension granted until	Request refused
	2021-09-17	2033-01-28

Legal status
	SPC term extension granted